• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Life Sciences | News, Analysis, Insights - HIT Consultant

Medable Partners with Google Cloud to Accelerate Clinical Trials

by Fred Pennic 10/30/2024 Leave a Comment

Medable Partners with Google Cloud to Accelerate Clinical Trials

What You Should Know:  - Medable Inc., a provider of decentralized and hybrid clinical trial solutions, is collaborating with Google Cloud to make its Digital and Decentralized Clinical Trial Platform available on the Google Cloud Marketplace.  - The strategic partnership will empower life sciences companies to accelerate clinical development by leveraging Google Cloud's cutting-edge infrastructure and AI capabilities. Streamlining Clinical Trials with Medable and Google
Read More

Enhancing CNS Clinical Trials: Medidata and Cogstate’s Collaborative Solution

by Syed Hamza Sohail 10/30/2024 Leave a Comment

Enhancing CNS Clinical Trials: Medidata and Cogstate’s Collaborative Solution

What You Should Know: -  Medidata, a Dassault Systèmes brand and the leading provider of clinical trial solutions to the life sciences industry, today announced a partnership with neuroscience solutions leader Cogstate to reshape clinical trials and outcomes measurement for central nervous system (CNS) diseases across neurodegenerative, psychiatric, motor, and rare neurodevelopmental disorders, among others. -  Together, the companies will deliver an improved experience, supported
Read More

Quris-AI Acquires Nortis to Enhance Bio-AI Platform and Advance Drug Safety Prediction

by Fred Pennic 10/29/2024 Leave a Comment

Quris-AI Acquires Nortis to Enhance Bio-AI Platform and Advance Drug Safety Prediction

What You Should Know:  - Quris-AI, a leading Bio-AI company revolutionizing drug development, has acquired Nortis, a pioneer in microphysiology systems (MPS) technology, formerly known as Numa Biosciences.  - The strategic acquisition will integrate Nortis's advanced Kidney-on-Chip technology into Quris-AI's Bio-AI platform, enhancing its ability to predict drug safety and efficacy in humans. Combining Cutting-Edge Technologies Nortis's Kidney-on-Chip models have been
Read More

Lindus Health Launches “All-in-One Women’s Health CRO” to Accelerate Clinical Trials

by Jasmine Pennic 10/29/2024 Leave a Comment

Lindus Health Launches "All-in-One Women's Health CRO" to Accelerate Clinical Trials

What You Should Know:  - Lindus Health, a leading innovator in clinical trial solutions, has announced the launch of its "All-in-One Women's Health CRO" offering.  - The comprehensive suite of services and technology is specifically designed to support the unique needs of companies developing treatments and diagnostics for women's health conditions. Addressing the Unique Challenges of Women's Health Research Clinical trials for women's health products require specialized
Read More

The Double-Edged Sword of GenAI in the Life Sciences Sector

by Rob Juncker, CTO of Code42 (now part of Mimecast) 10/28/2024 Leave a Comment

The Double-Edged Sword of GenAI in the Life Sciences Sector

It’s said that data is the lifeblood of the modern enterprise. While that’s certainly true, it’s also true that there is perhaps no industry as dependent on data – and protecting it – as the life sciences sector. Of course, the very nature of data has evolved significantly over the past few years. What once consisted of straightforward records and research results has now expanded to include highly complex and distributed datasets generated by advanced technologies like genomics, AI-driven
Read More

Abbott Launches Clinical Trial to Optimize Heart Failure Treatment with AI-Powered Monitoring

by Jasmine Pennic 10/24/2024 Leave a Comment

Abbott Pioneers New Clinical Trial to Optimize Heart Failure Treatment with AI-Powered Monitoring

What You Should Know:  - Abbott, a global healthcare leader, has announced a new clinical trial, TEAM-HF,  designed to improve outcomes for patients with worsening heart failure.  - The first-of-its-kind trial will leverage AI and Abbott's CardioMEMS™ HF System to identify patients who may benefit from earlier intervention with advanced therapies, such as a HeartMate 3™ left ventricular assist device (LVAD). Addressing the Challenges of Advanced Heart Failure Heart
Read More

Pangea and Knight Cancer Institute collab to advance precision oncology for metastatic cancer

by Syed Hamza Sohail 10/24/2024 Leave a Comment

Pangea and Knight Cancer Institute collab to advance precision oncology for metastatic cancer

What You Should Know: - Pangea Biomed, the startup behind the advanced cancer response prediction platform ENLIGHT, today announced the beginning of a pilot collaboration with the Knight Cancer Institute at Oregon Health and Science University (OHSU).  - This collaboration will explore the ability to predict personalized cancer treatment response using data processed through the Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) Clinical Trials
Read More

How A Human-AI Partnership Can Boost Clinical Trial Recruitment

by Cara Brant, CEO of Clinical Trial Media 10/23/2024 Leave a Comment

How A Human-AI Partnership Can Boost Clinical Trial Recruitment

The demand for clinical trial testing is rising, from over 260,000 trials conducted in 2018 to nearly double that figure in 2024. This means that more trials are being conducted simultaneously than ever—a factor that adds to the already challenging process of finding clinical trial participants. Because trial sponsors are struggling to find sufficient numbers of suitable participants, 80% of the world’s more than 450,000 clinical trials are at risk of
Read More

Combining an Omnichannel Strategy with Benchmarking and Metrics to Engage Healthcare Professionals

by Christopher Wooden, Senior Director, Business Marketing, IQVIA 10/22/2024 Leave a Comment

Combining an Omnichannel Strategy with Benchmarking and Metrics to Engage Healthcare Professionals

A critical aspect of any pharma/life sciences commercialization strategy is to develop and deploy effective and meaningful ways to engage, inform and build trust with healthcare providers (HCPs). A brand can best meet its clinical and commercial objectives throughout its lifecycle by offering a well-orchestrated mix of information and resources in different digital and in-person formats that HCPs can easily access.  As with any multifaceted marketing and commercialization strategy, brand
Read More

ixlayer Launches At-Home CBC Testing for Direct-to-Patient Biopharma Programs

by Syed Hamza Sohail 10/22/2024 Leave a Comment

ixlayer Launches At-Home CBC Testing for Direct-to-Patient Biopharma Programs

What You Should Know: - xlayer, the leading cloud-based platform powering an end-to-end direct-to-patient (DTP) healthcare experience, announced availability of a Complete Blood Count (CBC) test with at-home sample collection. This move supports biopharma partners who want to accelerate virtual care and reduce barriers to care for patients. - Available through ixEngage, ixlayer’s DTP biopharma solution, biopharma companies can develop programs to include a CBC test,
Read More

  • Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 26
  • Go to page 27
  • Go to page 28
  • Go to page 29
  • Go to page 30
  • Interim pages omitted …
  • Go to page 101
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

Aligning IT & Clinical Teams: How to Reduce Friction and Improve Communication

Most-Read

CB Insights Q2 2026 State of Digital Health Report: Fewest Deals in Over a Decade as Median Sizes Rise

CB Insights Q2 2026 State of Digital Health Report: Fewest Deals in Over a Decade as Median Sizes Rise

mount-sinai-launches-epic-chart-with-art-nursing-ambient-ai

Mount Sinai Medical Center Extends Epic’s Ambient AI to Inpatient Nursing

M&A: Tempus AI to Acquire Personalis for $1.5B to Expand Precision Oncology and MRD Monitoring

M&A: Tempus AI to Acquire Personalis for $1.5B to Expand Precision Oncology and MRD Monitoring

Why Brain Health Is Entering Its Infrastructure Era

Brain Health’s Infrastructure Era: Proving Clinical Outcomes with Integrated Neuromotor Tracking

Why Catholic Health Inked a $500M Care Alliance with GE HealthCare to Automate Outpatient Triage

Catholic Health Inks $500M Care Alliance with GE HealthCare to Automate Outpatient Triage

KLAS Global HIT Trends 2026 Report: Artificial Intelligence Becomes the Top Investment Priority

KLAS Global HIT Trends 2026 Report: Artificial Intelligence Becomes the Top Investment Priority

Optum Partners with Anthropic to Deploy Claude Across Healthcare Claims and Revenue Workflows

Optum Partners with Anthropic to Deploy Claude Across Healthcare Claims and Revenue Workflows

Rock Health H1 2026 Digital Health Funding Recap: Startups Hit $7.4B in Venture Rebound

Rock Health H1 2026 Digital Health Funding Recap: Startups Hit $7.4B in Venture Rebound

M&A: ResMed to Sell MatrixCare Business to Frazier Healthcare Partners for $450M

M&A: ResMed to Sell MatrixCare Business to Frazier Healthcare Partners for $450M

The Real Risk in Healthcare AI Isn’t the Model. It’s the Data. 

Clinical Data Fidelity: The Real Blindspot in Healthcare AI Strategy

Secondary Sidebar

Footer

Company

  • About Us
  • 2026 Editorial Calendar
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |